2009
DOI: 10.1016/j.chembiol.2009.06.012
|View full text |Cite|
|
Sign up to set email alerts
|

Hoiamide A, a Sodium Channel Activator of Unusual Architecture from a Consortium of Two Papua New Guinea Cyanobacteria

Abstract: Summary Hoiamide A, a novel bioactive cyclic depsipeptide, was isolated from an environmental assemblage of the marine cyanobacteria Lyngbya majuscula and Phormidium gracile collected in Papua New Guinea. This stereochemically complex metabolite possesses a highly unusual structure which likely derives from a mixed peptide-polyketide biogenetic origin, and includes a peptidic section featuring an acetate extended and S-adenosyl methionine modified isoleucine moiety, a triheterocyclic fragment bearing two a-met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
80
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 86 publications
(80 citation statements)
references
References 56 publications
(67 reference statements)
0
80
0
Order By: Relevance
“…12) was purified as the active principle, causing a dose-dependent and rapid influx of [Na + ] in neocortical neurons. 167 Hoiamide A, however, produced a maximum Na + influx less than the full VGSC agonist batrachotoxin, suggesting that hoiamide A is a partial agonist. 167 The MOA of hoiamide A was interrogated using the VGSC inhibitor tetrodotoxin, NMDA receptor antagonist MK-801 and AMPA receptor antagonist NBQX, monitoring for hoiamide A-induced elevation in [Na + ] in neocortical neurons.…”
Section: Mechanisms Of Action and Direct Cellular Targets Of Biologmentioning
confidence: 87%
See 3 more Smart Citations
“…12) was purified as the active principle, causing a dose-dependent and rapid influx of [Na + ] in neocortical neurons. 167 Hoiamide A, however, produced a maximum Na + influx less than the full VGSC agonist batrachotoxin, suggesting that hoiamide A is a partial agonist. 167 The MOA of hoiamide A was interrogated using the VGSC inhibitor tetrodotoxin, NMDA receptor antagonist MK-801 and AMPA receptor antagonist NBQX, monitoring for hoiamide A-induced elevation in [Na + ] in neocortical neurons.…”
Section: Mechanisms Of Action and Direct Cellular Targets Of Biologmentioning
confidence: 87%
“…167 Hoiamide A, however, produced a maximum Na + influx less than the full VGSC agonist batrachotoxin, suggesting that hoiamide A is a partial agonist. 167 The MOA of hoiamide A was interrogated using the VGSC inhibitor tetrodotoxin, NMDA receptor antagonist MK-801 and AMPA receptor antagonist NBQX, monitoring for hoiamide A-induced elevation in [Na + ] in neocortical neurons. 167 Tetrodotoxin A and MK-801, but not NBQX, caused a significant decrease in hoiamide A-induced Na + influx and an increase in maximum response of Na + influx with pyrethroid and brevetoxin 3 cotreatment.…”
Section: Mechanisms Of Action and Direct Cellular Targets Of Biologmentioning
confidence: 87%
See 2 more Smart Citations
“…The alkaloidal steroid batrachotoxin (BTX) is found in frog, bird, and insect species and has served as a primary tool for determining site 2 functional roles in Na V channels [207]. Antillatoxin and hoiamide are two structurally unique Na V agonists isolated from marine cyanobacteria [208,209]. Both molecules were found to partially displace [ Site 2 toxins share the characteristic of preferential binding to open-state Na V channels and are able to modulate several functional Na V properties.…”
Section: Sitementioning
confidence: 99%